tomeko

ABetaA21G amyloidosis

Just diagnosed with ABetaA21G amyloidosis?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees ABetaA21G amyloidosis, look for clinical trials, and connect with others living with it — all in one place.

Open the full ABetaA21G amyloidosis hub →

Overview

ABetaA21G amyloidosis is a rare condition. Also known as ABeta amyloidosis, Flemish type, ABetaA21G-related amyloidosis, HCHWA, Flemish type, Hereditary cerebral hemorrhage with amyloidosis, Flemish type. Tomeko brings together the specialists, research, clinical trials, treatments and community for ABetaA21G amyloidosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:324718 · OMIM 605714 · ICD-10 E85.4+, I68.0* · GARD 0017492

Find care for ABetaA21G amyloidosis

Authoritative references for ABetaA21G amyloidosis

Common questions

I was just diagnosed with ABetaA21G amyloidosis — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees ABetaA21G amyloidosis, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for ABetaA21G amyloidosis?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat ABetaA21G amyloidosis, filtered to your area.

Are there clinical trials for ABetaA21G amyloidosis?

Tomeko shows live, recruiting studies for ABetaA21G amyloidosis from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com